Transitions in Treating mCRPC: Abiraterone after Sipuleucel-T

Transitions in Treating mCRPC: Abiraterone after Sipuleucel-T

Alicia Morgans, MD presents the treatment of a prostate cancer patient throughout a period of disease progression, and provides the rationale for patient selection and drug selection for treatments.

Alicia K. Morgans, MD
Assistant Professor of Medicine
Vanderbilt University Medical Center